Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph... von Brose, Marcia S, Dr, Cabanillas, Maria E, MD, Cohen, Ezra E W, Prof, Wirth, Lori J, MD, Riehl, Todd, PharmD, Yue, Huibin, PhD, Sherman, Steven I, Prof, Sherman, Eric J, MD

Volltext

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial von Brose, Marcia S, Robinson, Bruce, Sherman, Steven I, Krajewska, Jolanta, Lin, Chia-Chi, Vaisman, Fernanda, Hoff, Ana O, Hitre, Erika, Bowles, Daniel W, Hernando, Jorge, Faoro, Leonardo, Banerjee, Kamalika, Oliver, Jennifer W, Keam, Bhumsuk, Capdevila, Jaume

Volltext

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer von Wirth, Lori J., Brose, Marcia S., Sherman, Eric J., Licitra, Lisa, Schlumberger, Martin, Sherman, Steven, Bible, Keith C., Robinson, Bruce, Rodien, Patrice, Godbert, Yann, De La Fouchardiere, Christelle, Newbold, Kate, Nutting, Christopher, Misir, Soamnauth, Xie, Ran, Almonte, Ana, Ye, Weifei, Cabanillas, Maria E.

Volltext

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, p... von Brose, Marcia S, Cabanillas, Maria E, Cohen, Ezra E W, Wirth, Lori J, Riehl, Todd, Yue, Huibin, Sherman, Steven I, Sherman, Eric J

Volltext

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial von Brose, Marcia S, Dr, Nutting, Christopher M, Prof, Jarzab, Barbara, Prof, Elisei, Rossella, Prof, Siena, Salvatore, MD, Bastholt, Lars, MD, de la Fouchardiere, Christelle, MD, Pacini, Furio, Prof, Paschke, Ralf, Prof, Shong, Young Kee, Prof, Sherman, Steven I, Prof, Smit, Johannes W A, Prof, Chung, John, MD, Kappeler, Christian, PhD, Peña, Carol, PhD, Molnár, István, MD, Schlumberger, Martin J, Prof

Volltext

Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor World von Cabanillas, Maria E, Busaidy, Naifa L, Sherman, Steven I

Volltext

Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape von Nies, Marloes, Vassilopoulou-Sellin, Rena, Bassett, Roland L, Yedururi, Sireesha, Zafereo, Mark E, Cabanillas, Maria E, Sherman, Steven I, Links, Thera P, Waguespack, Steven G

Volltext

Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial... von Kiyota, Naomi, Tahara, Makoto, Robinson, Bruce, Schlumberger, Martin, Sherman, Steven I., Leboulleux, Sophie, Lee, Eun Kyung, Suzuki, Takuya, Ren, Min, Fushimi, Kazuma, Wirth, Lori J.

Volltext

Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial von Brose, Marcia S., Robinson, Bruce G., Sherman, Steven I., Jarzab, Barbara, Lin, Chia‐Chi, Vaisman, Fernanda, Hoff, Ana O., Hitre, Erika, Bowles, Daniel W., Sen, Suvajit, Oliver, Jennifer W., Banerjee, Kamalika, Keam, Bhumsuk, Capdevila, Jaume

Volltext

Cabozantinib in Progressive Medullary Thyroid Cancer von Elisei, Rossella, Schlumberger, Martin J, Müller, Stefan P, Schöffski, Patrick, Brose, Marcia S, Shah, Manisha H, Licitra, Lisa, Jarzab, Barbara, Medvedev, Viktor, Kreissl, Michael C, Niederle, Bruno, Cohen, Ezra E W, Wirth, Lori J, Ali, Haythem, Hessel, Colin, Yaron, Yifah, Ball, Douglas, Nelkin, Barry, Sherman, Steven I

Volltext

Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers von Sherman, Steven I.

Volltext

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task... von Haugen, Bryan R., Alexander, Erik K., Bible, Keith C., Doherty, Gerard M., Mandel, Susan J., Nikiforov, Yuri E., Pacini, Furio, Randolph, Gregory W., Sawka, Anna M., Schlumberger, Martin, Schuff, Kathryn G., Sherman, Steven I., Sosa, Julie Ann, Steward, David L., Tuttle, R. Michael, Wartofsky, Leonard

Volltext

Targeted therapies for thyroid tumors von Sherman, Steven I

Volltext

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer von Schlumberger, Martin, Jarzab, Barbara, Cabanillas, Maria E, Robinson, Bruce, Pacini, Furio, Ball, Douglas W, McCaffrey, Judith, Newbold, Kate, Allison, Roger, Martins, Renato G, Licitra, Lisa F, Shah, Manisha H, Bodenner, Donald, Elisei, Rossella, Burmeister, Lynn, Funahashi, Yasuhiro, Ren, Min, O'Brien, James P, Sherman, Steven I

Volltext

Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT) von Wirth, Lori J., Tahara, Makoto, Robinson, Bruce, Francis, Sanjeev, Brose, Marcia S., Habra, Mouhammed Amir, Newbold, Kate, Kiyota, Naomi, Dutcus, Corina E., Mathias, Elton, Guo, Matthew, Sherman, Steven I., Schlumberger, Martin

Volltext

Targeted therapy of thyroid cancer von Sherman, Steven I.

Volltext

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer von Schlumberger, Martin, Tahara, Makoto, Wirth, Lori J, Robinson, Bruce, Brose, Marcia S, Elisei, Rossella, Habra, Mouhammed Amir, Newbold, Kate, Shah, Manisha H, Hoff, Ana O, Gianoukakis, Andrew G, Kiyota, Naomi, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Dutcus, Corina E, de las Heras, Begoña, Zhu, Junming, Sherman, Steven I

Volltext

BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer von Falchook, Gerald S., Millward, Michael, Hong, David, Naing, Aung, Piha-Paul, Sarina, Waguespack, Steven G., Cabanillas, Maria E., Sherman, Steven I., Ma, Bo, Curtis, Martin, Goodman, Vicki, Kurzrock, Razelle

Volltext

Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer von Haugen, Bryan R, Sherman, Steven I

Volltext

Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers von Hofmann, Marie-Claude, Kunnimalaiyaan, Muthusamy, Wang, Jennifer R, Busaidy, Naifa L, Sherman, Steven I, Lai, Stephen Y, Zafereo, Mark, Cabanillas, Maria E

Volltext